$QUCY 4 SEC Filings

Filed On	Filing
12 Aug 2026	Form 4: Caragol William J, Chief Financial Officer Granted 212,500 Stock Option (Right to Buy)
07 Aug 2026	Form 4: Lazar David E., Director Received 55,057,500 shares by conversion ($6.56B)
05 Aug 2026	Form 4: Ben-Tzvi Avraham, Director Received 112,259 shares as a grant or award
04 Aug 2026	Form 4: O'Rourke Peter, Director Granted 190,840 Stock Option (Right to Buy)
04 Aug 2026	Form 4: Natan David, Director Granted 190,840 Stock Option (Right to Buy)
04 Aug 2026	Form 4: Caragol William J, Chief Financial Officer Granted 212,500 Stock Option (Right to Buy)
04 Aug 2026	Form 4: Buffalino Louis R., Director Granted 425,000 Stock Option (Right to Buy)
07 Jul 2026	Form 4: O'Rourke Peter, Director Granted 112,859 Stock Option (Right to Buy)
26 May 2026	Form 4: Ben-Tzvi Avraham, Director Received 137,141 shares as a grant or award
21 May 2026	Form 4: Natan David, Director Received 137,141 shares as a grant or award
28 Apr 2026	Form 4: Lazar David E., Director Granted 1,000,000 Series D Preferred Shares ($1.5M) · Granted 1,000,000 Series E Preferred Shares ($1.5M)
03 Mar 2026	Form 4: Lazar David E., Director Granted 1,000,000 Series A Preferred Shares · Granted 1,000,000 Series B Preferred Shares · Granted 1,000,000 Series C Preferred Shares
19 Feb 2026	Form 4: Caragol William J, Chief Financial Officer Received 290,000 shares as a grant or award
19 Feb 2026	Form 4: Dreismann Heinrich, Director Received 45,000 shares as a grant or award
19 Feb 2026	Form 4: Tibbitts Gregory J, Director Received 45,000 shares as a grant or award
19 Feb 2026	Form 4: Baechler Guido, Director Received 440,000 shares as a grant or award
16 Jan 2026	Form 4: Donahue Kevin Michael, 10% owner Bought 643,850 shares ($259B)

Comments